3Bymaster FP, Rasmussen K, Calligaro DO, et al. In vitro and in vivo bio- chemistry of olanzapine : a novel, atypical antipsychotic drug. J Clin Psy- chiatry, 1997,58 ( supple l 0 ) :20-36.
1Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine - fluoxetine combination in the treatment of bipolar 1 depression [ J ]. Archives of General Psychiatry,2003,60 : 1079-1088.
2Moffitt TE, Harrington H, Caspi A, et al. Depression and general anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry, 2007,64:651-660.
3Aina Y, Susman JL. Understanding comorbidity with depression and anxiety disorders. JAOA,2006,106 ( Supp 12) :9-14.
4Strakowski SM, DelBello MP, Adler CM, et al. Atypical antipsychotics in the treatment of bipolar disorder. Expert Opin Pharmacother, 2003,4:751-760.
5Tohen M, Shelton R, Tollefson GD, et al. Olanzapine pius Fluoxetine : double-blind and open-label results in treatment-resistant depressive disorder. Presented at the 12th annual meeting of the European College of Neuropsychopharmocology, 1999, 21～25
6Zhang W, Perry KW, Wong DT, et al. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology, 2000, 23(3) : 250
7Anath J. Treatment-resistant depression. Psychother Psychosom, 1998, 67(2) : 61
8Svestka J, Synek O. Does olanzapine have antidepressant effect? A double-blind amitriptyline-controlled study (abstract). Int J Neuropsychopharmacol, 2000, 3(suppl 1) : 251
9Shelton RC, Tollefson G, Tohen M, et al. A novel augwntation strategy for treating resistant depression. Am J Psychiatry, 2001, 158(1) : 131
10Adson DE, Kushner MG, Eiben KM, et al. Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors.Depress Anxiety, 2004, 19(2) : 121
7Katagiri H, Tohen M, McDonnell DP, et al. Efficacy and safety of olanzapine for treatment of patients with bipo- lar depression: Japanese subpopulation analysis of a randomized, double blind, placebo-controlled study[J]. BMC Psychiatry, 2013,13(1) :138.
8Sani G, Kotzalidis GD, Vohringer P, et al. Effectiveness of short term olanzapine in patients with bipolar I disor- der, with or without comorbidity with substance use disorder[J]. J Clin Psychopharmacol,2013,33(2) : 231- 235.
9Lanbert G,Johansson M,Agren H,et al.Reduced brain norepinephfine and dopamine release in treatment-resistantdepressive illness:evidence in support of catecholaminehypothesis of mood disorders[J].J Arch Gen Psychiatry,2005,57(7):787-793.
10Keck PE,Strakowski SM,McElroy SLThe efficacy of a typicalantipsychotics in the treatment of depressive symptom,hostility,andsuicidality in patients with schizophrenia[J].J Clin Psychiatry,2000,61(suppI3):4-9.
